Page 19 - Fluorescence-guided cancer surgery

24. Moore GE, Peyton WT. The clinical use of uorescein in neurosurgery; the localization of brain tumors. J Neurosurg 1948;5:392-398.
25. van der Vorst JR, Vahrmeijer AL, Hutteman M et al. Near-infrared uorescence imaging of a solitary brous tumor of the pancreas using methylene blue. World J Gastrointest Surg 2012;4:180-184.
26. Stummer W, Stocker S, Wagner S et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin uorescence. Neurosurgery 1998;42:518-525.
27. Schaafsma BE, Mieog JS, Hutteman M et al. The clinical use of indocyanine green as a near-infrared uorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 2011;104:323-332.
28. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR e ect in macromolecular therapeutics: a review. J Control Release 2000;65:271-284.
29. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387- 6392.
30. Heijblom M, Klaase JM, van den Engh FM, van Leeuwen TG, Steenbergen W, Manohar S. Imaging tumor vascularization for detection and diagnosis of breast cancer. Technol Cancer Res Treat 2011;10:607-623.
31. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study. Endocr Pathol 1995;6:115-124.
32. Padhani AR, Dzik-Jurasz A. Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 2004;15:41-57.
33. Ishizawa T, Fukushima N, Shibahara J et al. Real-time identi cation of liver cancers by using indocyanine green uorescent imaging. Cancer 2009;115:2491-2504.
34. Winer JH, Choi HS, Gibbs-Strauss SL, Ashitate Y, Colson YL, Frangioni JV. Intraoperative Localization of Insulinoma and Normal Pancreas Using Invisible Near-Infrared Fluorescent Light. Ann Surg Oncol 2009.
35. Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H. Near infrared uorescence- guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer 2011;129:1671-1677.
36. Litvack ZN, Zada G, Laws ER, Jr. Indocyanine green uorescence endoscopy for visual
di erentiation of pituitary tumor from surrounding structures. J Neurosurg 2012;116:935-941.
37. van der Vorst JR, Schaafsma BE, Hutteman M et al. Near-infrared uorescence-guided resection of colorectal liver metastases. Cancer 2013;119:3411-3418.
38. van der Vorst JR, Schaafsma BE, Verbeek FP et al. Intraoperative near-infrared uorescence imaging of parathyroid adenomas with use of low-dose methylene blue. Head Neck 2013.
39. Altintas I, Kok RJ, Schi elers RM. Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies. Eur J Pharm Sci 2012;45:399- 407.
40. Choi HS, Gibbs SL, Lee JH et al. Targeted zwitterionic near-infrared uorophores for improved optical imaging. Nat Biotechnol 2013;31:148-153.
41. Hyun H, Park MH, Owens EA et al. Structure- inherent targeting of near-infrared uorophores for parathyroid and thyroid gland imaging. Nat Med 2015;21:192-197.
42. Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM. Targeting tumors with nanobodies for cancer imaging and therapy. J Control Release 2013;172:607- 617.
43. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
44. van Dam GM, Crane LM, Themelis G et al. Intraoperative tumor-speci c uorescence imaging in ovarian cancer by folate receptor- alpha targeting: rst in-human results. Nat Med 2011;Sep 18;17(10):1315-9.
45. Burggraaf J, Kamerling IM, Gordon PB et al. Detection of colorectal polyps in humans using an intravenously administered uorescent peptide targeted against c-Met. Nat Med 2015.
46. Rosenthal EL, Warram JM, de BE et al. Safety and Tumor Speci city of Cetuximab- IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res 2015;21:3658- 3666.
47. Lamberts LE, Koch M, de jong JS et al. Tumor- speci c uptake of uorescent bevacizumab- IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin Cancer Res 2016.
48. Whitley MJ, Cardona DM, Lazarides AL et al. A mouse-human phase 1 co-clinical trial of a protease-activated uorescent probe for imaging cancer. Sci Transl Med 2016;8:320ra4.
General introduction and thesis outline 17